May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Topical 0.5% Moxifloxacin Significantly Reduces Pre–Operative Conjunctival Bacteria
N. Hu; L. Espinosa; S. Sinnar; P.R. Egbert; K. Singh; H.–K.V. Ho; C.N. Ta; H. Mino de Kaspar
Author Affiliations & Notes
  • N. Hu
    Ophthalmology, Stanford University, Palo Alto, CA
  • L. Espinosa
    Ophthalmology, Stanford University, Palo Alto, CA
  • S. Sinnar
    Ophthalmology, Stanford University, Palo Alto, CA
  • P.R. Egbert
    Ophthalmology, Stanford University, Palo Alto, CA
  • K. Singh
    Ophthalmology, Stanford University, Palo Alto, CA
  • H.–K.V. Ho
    Ophthalmology, Stanford University, Palo Alto, CA
  • C.N. Ta
    Ophthalmology, Stanford University, Palo Alto, CA
  • H. Mino de Kaspar
    Ophthalmology, Stanford University, Palo Alto, CA
    Department of Ophthalmology, Ludwig–Maximilians–University, Munich, Germany
  • Footnotes
    Commercial Relationships  N. Hu, None; L. Espinosa, None; S. Sinnar, None; P.R. Egbert, None; K. Singh, None; H.V. Ho, None; C.N. Ta, Alcon Inc. R; Santen Inc. R; Allergan Inc. R; H. Mino de Kaspar, None.
  • Footnotes
    Support  Alcon Inc. , Hannelore–Georg Zimmermann Foundation
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 2782. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Topical 0.5% Moxifloxacin Significantly Reduces Pre–Operative Conjunctival Bacteria
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      N. Hu, L. Espinosa, S. Sinnar, P.R. Egbert, K. Singh, H.–K.V. Ho, C.N. Ta, H. Mino de Kaspar; Topical 0.5% Moxifloxacin Significantly Reduces Pre–Operative Conjunctival Bacteria . Invest. Ophthalmol. Vis. Sci. 2005;46(13):2782.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: To determine the efficacy of topical 0.5% moxifloxacin given for 1 day compared with 3 days before intraocular surgery in reducing conjunctival bacterial flora. Methods: A total of 60 eyes from 59 patients scheduled to undergo intraocular surgery were enrolled in this prospective randomized study. All patients received topical 0.5% moxifloxacin (4x/day) before surgery and were assigned to either control (1–day, n = 33) or study (3–day, n = 27) groups. Conjunctival cultures were obtained before (T0 as a baseline) and after (T1) the application of topical moxifloxacin using a moistened cotton swab. The swabs were inoculated and incubated for aerobic/anaerobic bacteria at 37°C for 6 days on blood/chocolate agars and in blood culture broth. All patients received topical 0.5% moxifloxacin three times in five–minute intervals one hour before surgery in addition to a 5% povidone–iodine (PVI) flush of the conjunctiva. Conjunctival cultures, anterior chamber aqueous fluid (ACF), and cannula (CA) samples were obtained immediately before the incision was made (T3) and at the conclusion of surgery (T4). Results: At baseline, there was no difference in the percentage of positive samples between the control (75.8 %) and study (81.5%) groups (P = 0.8309). The percentages of positive T1 cultures in the control and study were 30.3% and 33.3% respectively. Both groups were statistically less positive than their baselines (P = 0.0005 control, P = 0.0008 study). However, a comparison of control and study groups at T1 showed no significant difference (P = 1.0000). Less than 13% of cultures from T3 and T4, and less than 3% of ACF, and CA culture were positive in both groups. Coagulase–negative Staphylococcus (70.2%) was the most common bacteria among the total of 114 isolated strains. Conclusions: Prophylaxis with topical 0.5% moxifloxacin significantly reduces conjunctival bacterial flora in patients undergoing intraocular surgery. A one–day application of topical 0.5% moxifloxacin before surgery appears to be as effective as a three–day application in eliminating bacteria from the conjunctiva.

Keywords: endophthalmitis • bacterial disease • antibiotics/antifungals/antiparasitics 
© 2005, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept